Home
About
Services
Partners
Client Portfolio
News
Contact
Emerging markets and equities reel as dollar flexes muscles
September 5, 2018
Bayer cuts forecasts on Monsanto delay as lawsuits pile up
September 5, 2018
0
Bayer open for drug licensing deals, cutting debt remains priority
Published by
Muller&Green
at
September 5, 2018
Categories
RSS
Tags
Bayer is ready to spend money on more drug licensing agreements like last year’s deal with Loxo Oncology but its priority is to reduce debt after the takeover of Monsanto.
Powered by
WPeMatico
Muller&Green
Related posts
June 18, 2020
Chanel warns virus impact will linger on luxury sector
Read more
June 18, 2020
IMF says deeper-than-expected contraction in U.S. economy likely in second quarter
Read more
June 18, 2020
Prudential sells Jackson equity stake to Apollo-backed Athene for $500 million
Read more